FGF2 and sarcoidosis: The aim of this study was to assess the serum levels of those four proangiogenic and profibrotic markers VEGF, TGF-β1, FGF-2 and PDGF-AB in sarcoidosis and if there is an association of these serum markers with pulmonary impairment and quality of life.